-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...
More »SEARCH RESULT
Total Matching Records found : 283
Law on sexual harassment at work fosters new business -Namrata Singh
-The Times of India MUMBAI: Enterprising lawyers and gender equality experts have spotted a business opportunity in the new law against sexual harassment of women at work. With the Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013 raising major concerns with respect to corporate liability and a potential threat to reputation on non-compliance, organizations are turning to the pros. This new breed of consultants helps companies with gender...
More »Get over the growth fetish -Ashish Kothari
-The Hindu Business Line Perpetual growth is a piece of nonsense. The focus should be on protecting livelihoods through sustainable means Construct a building, demolish it, reconstruct, break it down again, and go on repeating this meaningless exercise. You will have economic growth, as currently measured. But no net gain in employment during the endless cycle of construction and demolition, no net increase in productive capacity, and no appreciable change in poverty...
More »How the experts sank the UPA -Shekhar Swamy
-The Hindu Business Line A government run by a bevy of economists with no sense of the ground reality made mistakes. Some really big ones As the new government settles down to tackle the myriad problems confronting it, it's worth taking a quick glance at the principal reasons for the spectacular unravelling of the UPA-2 government. A defining characteristic of UPA-2 was that it was led by an economist and supported by prominent...
More »Conflict of interest in setting norms for pharmaceuticals in WHO -Rema Nagarajan
-The Times of India NEW DELHI: The World Health Organisation's (WHO) work of setting up norms and standards for production of medicines seems to be flawed by a fundamental conflict of interest. At the heart of its standard setting work is an entity the International Conference on Harmonization (ICH) in which majority of the WHO member countries have no voting rights and which is dominated by pharmaceutical industry groups. This glaring...
More »
